Lexicon Pharmaceuticals, Inc. · NASDAQ:LXRX

Invus Global Management, LLC reported a 9.60% stake in Lexicon Pharmaceuticals, Inc. (Schedule 13D/A)

Event Apr 30, 2026 · Filed May 8, 2026

Invus Global Management, LLC reported a 9.60% stake in Lexicon Pharmaceuticals, Inc., 42,765,057 shares, with active intent on Apr 30, 2026. Filed May 8, 2026 (Schedule 13D/A).

Stake: 9.60%
Shares: 42,765,057
Intent: Active
What changed: Stake changed
Filed together: 18 holders

The filing in full

Holder	Stake	Shares
Invus, L.P.	9.60%	42,765,057
Invus Advisors, L.L.C.	9.60%	42,765,057
Invus Public Equities, L.P.	1.70%	7,362,368
Invus Public Equities Advisors, LLC	1.70%	7,362,368
Invus Global Management, LLC	9.60%	42,765,057
Siren, L.L.C.	9.60%	42,765,057
Avicenna Life Sci Master Fund LP	0.30%	1,538,462
Avicenna Life Sci Master GP LLC	0.30%	1,538,462
Invus US Partners LLC	1.20%	5,451,204
Ulys, L.L.C.	1.60%	6,989,666
Raymond Debbane	11.70%	51,878,643
Artal Participations S.a r.l.	39.40%	175,156,062
Artal International S.C.A.	39.40%	175,156,062
Artal International Management S.A.	39.40%	175,156,062
Artal Group S.A.	39.40%	175,156,062
Westend S.A.	39.40%	175,156,062
Stichting Administratiekantoor Westend	39.40%	175,156,062
Amaury Wittouck	39.40%	175,156,062

Source

View original at SEC

Related